1. Home
  2. TXMD vs PCLA Comparison

TXMD vs PCLA Comparison

Compare TXMD & PCLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TherapeuticsMD Inc.

TXMD

TherapeuticsMD Inc.

HOLD

Current Price

$1.67

Market Cap

21.3M

Sector

Health Care

ML Signal

HOLD

Logo PicoCELA Inc. American Depositary Shares

PCLA

PicoCELA Inc. American Depositary Shares

HOLD

Current Price

$0.16

Market Cap

18.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
TXMD
PCLA
Founded
2008
2008
Country
United States
Japan
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Building Products
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
21.3M
18.6M
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
TXMD
PCLA
Price
$1.67
$0.16
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
126.7K
748.5K
Earning Date
11-12-2025
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.03
N/A
Revenue
$2,796,000.00
$5,065,197.00
Revenue This Year
$427.09
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$277.12
N/A
Revenue Growth
75.19
5.26
52 Week Low
$0.70
$0.25
52 Week High
$2.44
$9.80

Technical Indicators

Market Signals
Indicator
TXMD
PCLA
Relative Strength Index (RSI) 51.54 15.27
Support Level $1.46 $0.27
Resistance Level $2.01 $0.33
Average True Range (ATR) 0.17 0.03
MACD -0.01 -0.01
Stochastic Oscillator 37.93 5.25

Price Performance

Historical Comparison
TXMD
PCLA

About TXMD TherapeuticsMD Inc.

TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.

About PCLA PicoCELA Inc. American Depositary Shares

PicoCELA Inc specializes in manufacturing, installing, and servicing enterprise wireless mesh solutions. The company generates revenue from two main sources: product equipment sales, and Software as a Service (SaaS) and maintenance services. The company develops the PCWL series of mesh Wi-Fi access points, which utilize its proprietary PicoCELA Backhaul Engine (PBE) technology to enable wireless communication. The company outsources manufacturing and sells these devices directly to customers through distributors. Additionally, the company offers a cloud portal service in a SaaS model, allowing users to monitor connectivity and traffic at their access points. This platform also supports the installation of proprietary edge-computing software into the devices.

Share on Social Networks: